Prostalund AB (FRA:7PL0) EPS (Basic): €-0.51 (TTM As of Sep. 2025)


FRA:7PL0 Prostalund AB FRA:7PL0
10 GF Score
Price €0.00
GF Value €0.02
! 6 Warning Signs
View Full Analysis

What is Prostalund AB EPS (Basic)?

Prostalund AB FRA:7PL0 10 EPS (Basic) is €-0.51 as of Sep. 2025. GuruFocus rates FRA:7PL0 with a GF Score™ of 10/100 and a GF Value™ of €0.02. The stock has 6 warning signs investors should review.

Prostalund AB's basic earnings per share (Basic EPS) for the three months ended in Sep. 2025 was €-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.51.

Prostalund AB's EPS (Diluted) for the three months ended in Sep. 2025 was €-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.51.

Prostalund AB's EPS without NRI for the three months ended in Sep. 2025 was €-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was -0.51.

During the past 3 years, the average EPS without NRI Growth Rate was -2.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Prostalund AB's highest 3-Year average EPS without NRI Growth Rate was 43.20% per year. The lowest was -113.20% per year. And the median was 2.20% per year.

Prostalund AB  (FRA:7PL0) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Prostalund AB EPS (Basic) Related Terms

Prostalund AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Prostalund AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostalund AB EPS (Basic) Chart

Prostalund AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.00 -0.63 -0.73 -0.89 -0.60

Prostalund AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.21 -0.13 -0.16 -0.01
FRA:7PL0
10GF Score
Prostalund AB FRA:7PL0
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prostalund AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Prostalund AB's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.967-0)/68.447
=-0.03

Prostalund AB's Basic EPS for the quarter that ended in Sep. 2025 is calculated as

Basic EPS (Q: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.24-0)/31.124
=-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-0.51 mean?
Prostalund AB (FRA:7PL0) has a EPS (Basic) of €-0.51 as of Sep. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Prostalund AB and its competitors.
Is Prostalund AB's EPS (Basic) too high?
Prostalund AB's current EPS (Basic) is €-0.51. Overall, Prostalund AB has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Prostalund AB's EPS (Basic) compare to HCA and THC?
Prostalund AB's EPS (Basic) of €-0.51 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Prostalund AB and its competitors. Prostalund AB's current EPS (Basic) is €-0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prostalund AB stock overvalued right now?
Prostalund AB (FRA:7PL0) has a current EPS (Basic) of €-0.51. The stock's GF Value™ is €0.02, compared to a current price of €0.00 — trading 97.5% below its estimated fair value. The current EPS (Basic) is €-0.51. Prostalund AB's overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Prostalund AB (FRA:7PL0), the current EPS (Basic) is €-0.51 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prostalund AB (FRA:7PL0) Overvalued in 2026?

Based on GuruFocus' analysis, Prostalund AB stock appears to be undervalued. The current stock price of €0.00 is trading 97.5% below its estimated GF Value™ of €0.02.

Key valuation signals for FRA:7PL0:

  • EPS (Basic): €-0.51
  • GF Value™: €0.02 vs. price of €0.00 (97.5% below fair value)
  • GF Score™: 10/100 with 6 warning signs

No single metric tells the full story. See the FRA:7PL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prostalund AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 63
Prostalund AB develops, markets and sells urological products. The Company has a treatment concept (CoreTherm Concept) for personalized heat treatment for the condition benign prostatic hyperplasia, also known as BPH or BPE, which mainly affects men over the age of 50. It has developed a new platform, CoreTherm Eagle which includes an inbuilt computer, real-time temperature reading, patient data storage and inbuilt recommendations for treating physicians.
10GF Score

Get the complete analysis for FRA:7PL0

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price
€0.02
GF Value